GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Capital Expenditure

Curocell (XKRX:372320) Capital Expenditure : ₩-21,650.45 Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Curocell's cash flow for capital expenditures for the six months ended in Jun. 2023 was ₩-18,588.09 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2023 was ₩-21,650.45 Mil.

Curocell Capital Expenditure Historical Data

The historical data trend for Curocell's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Capital Expenditure Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
-3,553.91 -3,576.77 -9,299.19 -27,869.63 -21,650.45

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Capital Expenditure -9,636.07 -18,233.55 -18,588.09 -3,062.36

Curocell Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₩-21,650.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Capital Expenditure
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines